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Abstract
Background: Like many low- and middle-income countries, South Africa established a dedicated HIV monitoring
and evaluation (M&E) system to track the national response to HIV/AIDS. Its implementation in the public health
sector has however not been assessed. Since responsibility for health services management lies at the district (sub-
national) level, this study aimed to assess the extent to which the HIV M&E system is integrated with the overall
health system M&E function at district level. This study describes implementation of the HIV M&E system,
determines the extent to which it is integrated with the district health information system (DHIS), and evaluates
factors influencing HIV M&E integration.
Methods: The study was conducted in one health district in South Africa. Data were collected through key
informant interviews with programme and health facility managers and review of M&E records at health facilities
providing HIV services. Data analysis assessed the extent to which processes for HIV data collection, collation,
analysis and reporting were integrated with the DHIS.
Results: The HIV M&E system is top-down, over-sized, and captures a significant amount of energy and resources
to primarily generate antiretroviral treatment (ART) indicators. Processes for producing HIV prevention indicators are
integrated with the DHIS. However processes for the production of HIV treatment indicators by-pass the DHIS and
ART indicators are not disseminated to district health managers. Specific reporting requirements linked to ear-
marked funding, politically-driven imperatives, and mistrust of DHIS capacity are key drivers of this silo approach.
Conclusions: Parallel systems that bypass the DHIS represent a missed opportunity to strengthen system-wide
M&E capacity. Integrating HIV M&E (staff, systems and process) into the health system M&E function would mobilise
ear-marked HIV funding towards improving DHIS capacity to produce quality and timely HIV indicators that would
benefit both programme and health system M&E functions. This offers a practical way of maximising programme-
system synergies and translating the health system strengthening intents of existing HIV policies into tangible
action.
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Background
The purpose of monitoring and evaluation (M&E) is to
produce reliable and timely health information and use
it to evaluate policy, set priorities, plan, and monitor the
effectiveness and impacts of interventions [1,2]. In
recent years, many low- and middle-income countries
have established dedicated (or vertical) M&E systems for
their HIV programmes [3,4]. The anticipated aims of
such M&E systems have however not been realised in
many countries due to low financial investment in M&E
infrastructure, weak or ill-defined systems for collection,
analysis, and dissemination of HIV data, inadequately
trained data collectors, and insufficient technical capa-
city to transform HIV data into usable indicators [3,4].
The non-integration of HIV M&E systems with overall
health information systems is another important factor.
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parallel systems, often in a bid to improve the availabil-
ity of quality HIV information for decision-makers.
However, this intended benefit is often not realised
[3-7].
South Africa has established a vertical HIV M&E sys-
tem to monitor its national HIV programme [8]. In
South Africa’s decentralised health sector, the district
(sub-national) level of the health system is well-placed
to use information generated by this HIV M&E system
to monitor the HIV programme. However, it has not
been documented if and how the HIV M&E system
interacts with the district health information system
(DHIS) designed to monitor overall health system per-
formance at district level, or whether it affects the avail-
ability of HIV programme information at district level.
This paper addresses this gap.
Disease-specific programmes and health systems
The emergence of global health initiatives (GHI)-notably
the Global Fund for AIDS, TB and Malaria (GFATM)
and the Presidential Emergency Plan for AIDS Relief
(PEPFAR)-as major funders of HIV/AIDS interventions
in low- and middle-income countries-has raised ques-
tions about the sustainability of disease-specific (vertical
or targeted) programmes [9,10]. GHIs increase HIV
funding and services [11], but also fragment coordina-
tion by establishing parallel planning, coordination and
monitoring systems within recipient countries, and wor-
sen already weak health systems by diverting resources
from general health services [12,13]. This has prompted
calls to strengthen health systems and find ways of max-
imising positive synergies between disease-specific pro-
grammes and health systems [9,14].
Integration of disease-specific programmes into health
systems is one way of strengthening health systems and
maximising programme-system synergies [15]. Integra-
tion is largely understood in relation to the service
delivery function of health systems: e.g. combining two
or more disease-specific services at one delivery point,
incorporating disease-specific services into general care,
continuity of care over time or across levels, or working
across government sectors [16-19]. Health system
impacts of service integration are however inconclusive
due to poor evidence because of weak or incomparable
evaluation methodologies [18-20]. There is even less evi-
dence on how targeted programmes interact with health
system functions other than service delivery, such as
financing, M&E, or governance [13,18]. In practice pro-
grammes lie along a continuum from integrated to fully
vertical, and depending on the context, integrate with
different health system functions to varying extents
[10,13]. In the absence of conclusive evidence on effects
of integration, it is advised that countries adopt organi-
sational arrangements that optimise benefits for both
programmes and systems in their context-specific set-
tings [9].
The high cost of maintaining parallel disease-specific
programmes, and the potential benefits of integrated
services with unified finance, management and M&E
processes provide compelling reasons to adopt organisa-
tional arrangements that optimise programme integra-
tion, particularly in weak health system contexts [15].
Some even suggest there are very few instances when
integration should not be the norm [21]. Countries how-
ever need guidance on when and how to integrate dis-
ease-specific programmes to strengthen health systems.
For example, in South Africa health system strengthen-
ing is a stated HIV programme goal [22,23] but how to
achieve this is unclear. Documenting how the HIV pro-
gramme interacts with and affects health system func-
tions is a step towards clarity.
HIV programme and the health system in South Africa
South Africa’s post-apartheid HIV programme was
established in 1994, initially emphasising prevention.
Public sector antiretroviral therapy (ART) services were
introduced in 2004 with earmarked funding following
the Operational Plan for Comprehensive HIV/AIDS
Care Management and Treatment (comprehensive plan)
[22,24]. An HIV M&E system was established to moni-
tor the comprehensive plan [8,22], and after adoption of
the multi-sectoral HIV & AIDS and STI Strategic Plan
2007-2011 (NSP), the M&E framework was expanded to
include other sectors [23].
Health services in South Africa are largely funded
through the National Treasury. External funding consti-
tutes less than 1% of the National Department of Health
(NDOH) budget [25-27]. However, South Africa does
receive GHI funding (largely from GFATM [dispersed
to Government] and PEPFAR [dispersed to non-govern-
mental agencies]), the bulk of which goes to HIV/AIDS.
As such, external aid constitutes 26% of the govern-
ment’s HIV/AIDS budget [25].
The National Treasury funds health largely through an
annual unconditional block grant named the ‘equitable
share’ (based on population numbers and needs) which
is allocated to provincial governments, who then distri-
bute this between various departments including health.
In addition, the National Treasury allocates to each pro-
vincial government dedicated funding for HIV-this is
termed the conditional grant for HIV and AIDS [27].
Reporting on expenditure for conditional grants is dif-
ferent to that required for equitable share funding. The
Division of Revenue Act (DORA) provides the legislative
and accountability framework for the HIV and AIDS
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data as well as narrative and financial reports to the
National Treasury [28].
Health system decentralisation has also been a
national priority since 1994. As such, responsibility for
managing health service delivery is decentralised to the
district (sub-national) level [29,30]. A district health
information system (DHIS) has been established to sup-
port district health management teams (DHMT) in this
role [31,32]. The DHIS-a critical component of the
national health information system-collects public sector
facility data to produce a set of district health service
indicators. Ideally, the disease-specific HIV M&E system
should be a sub-component of a system-wide informa-
tion system like the DHIS [1]. As such, DHMTs would
be well-placed to integrate HIV information into overall
district health system management.
A national study however reports that programme
information generated through disease-specific M&E
systems is not necessarily made available to district
managers [33]. Though that report did not specify the
HIV M&E system, it highlights the need to understand
how the HIV M&E interacts with the health system
M&E function (the DHIS) to determine whether any
negative synergies between them affect the availability
and use of HIV information for district management.
This paper thus uses a district in South Africa as a case
study to determine the extent to which the HIV M&E is
integrated with the DHIS, and assess effects of the HIV
M&E on availability of HIV information at district level.
The paper also discusses factors influencing HIV M&E
integration, and proposes ideas for maximising HIV pro-
gramme-system synergies.
Methods
This cross-sectional descriptive study was conducted
during April to July 2009 in one of South Africa’sn i n e
provinces. This largely rural province is divided into 3
district municipalities (districts). Districts are further
split into several local municipalities (sub-districts) and
overseen by district and sub-district managers, respec-
tively. Each sub-district has several service delivery local
areas (clusters of clinics), each overseen by a local area
manager (or clinic supervisor). A manager at provincial
level oversees the HIV programme assisted by four
deputies-one each for prevention, care and support,
treatment, and M&E sub-programmes-supported by
assistant managers at provincial level and HIV pro-
gramme managers at district and sub-district levels.
The prevention sub-programme in the study site
included condom distribution, life skills and behaviour
change, VCT, PMTCT; and later post-exposure prophy-
laxis for rape survivors (PEP) and HIV/TB collaboration
(management for HIV-TB co-infected people) were
added. At the time of the study the PMTCT protocol
had just changed from single dose nevirapine (NVP) to
short-course NVP and zidovudine (AZT). Prevention
services were largely funded through equitable share
funding. The treatment sub-programme focused on
ART services whereby accredited comprehensive care,
management and treatment [CCMT] sites initiated
patients on ART, and down-referral sites managed those
already initiated and stabilized on ART. During the
study, there were 32 CCMT sites in the province (23 at
hospitals, 9 at community health centres, and none at
clinics). CCMT services were funded through the HIV
conditional grant. About 75% of the province’sc o n d i -
tional grant was allocated to CCMT services.
We purposively selected one of the three district
municipalities in the province (one of 46 district munici-
palities in the country) for practical reasons as we were
already working in that site. Like other district munici-
palities, our study site used the national DHIS and was
also required to report to national level on a set of
nationally-defined HIV indicators. We identified the
most functional of five sub-districts in our study district,
and within this, selected both CCMT sites and both
down-referral sites, and used stratified sampling to
select one clinic from each of seven local areas (the
strata) (Table 1). Only one of our selected health facil-
ities (a CCMT site) was NGO supported and thus
reported HIV data to its funders as well as government.
All our other facilities were fully government-funded
and did not report HIV data to external donors.
We interviewed four senior HIV programme managers
at provincial level and the operational managers of all 11
facilities where we also reviewed M&E documents. Ethi-
cal approval was granted by the University of the Wit-
watersrand and the Provincial Department of Health.
Interviews were in English, tape-recorded where con-
sented, transcribed, and analysed thematically.
The variables we measured are outlined in Table 2. To
describe the HIV M&E system design we assessed
whether it possessed the organisational attributes
required of a national M&E system including: a compre-
hensive M&E plan with clear goals, targets and
resources for its implementation, clear plans for data
collection and analysis of defined indicators, and an
appropriately staffed M&E unit to coordinate activities
[4,34]. To examine integration we adopted the methodo-
logical approach of Atun et al., [35] which measures the
extent to which governance, planning, service delivery,
demand generation, financing and M&E functions of
vertical programmes are integrated with those of the
health system. We assessed only the M&E function and
examined the following M&E activities: data collection,
collation and reporting, and analysis. Guided by defini-
tions of integration as shared resources and technologies
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[21,35], we measured the extent of integration as “full
integration” if M&E activities and resources and coordi-
nation were shared between the HIV M&E system and
the DHIS, “partial” if there was some, and “no integra-
tion” if there was no sharing. We measured availability
of HIV indicators as the outcome of interest. Although
information use is the ultimate purpose of an M&E sys-
tem [1,7], availability can be a marker of M&E system
performance [4].
Results
Design of the HIV M&E system
W ef o u n dt h a tt h eH I VM & Ew a sd e s i g n e da tn a t i o n a l
level, in accord with the national HIV programme M&E
framework. The national level defined what HIV data to
collect and report (these changed as services were modi-
fied or added) and designed the data recording and col-
lation forms. Respondents reported that conditional
g r a n tf u n d i n gw a su s e dt oe s t a b l i s ha nH I VM & Eu n i t
at provincial level and to appoint an M&E unit manager
and a data clerk at each ART (CCMT) site to specifi-
cally coordinate the production of ART indicators. The
production of HIV prevention information was
coordinated by the provincial health information unit
which managed the DHIS. This unit was staffed by an
information manager and a health information officer,
and supported by one information officer and one data
clerk each at district and sub-district levels, respectively.
The production of HIV information
Our data showed that HIV prevention data were manu-
ally recorded on four different tick registers which were
in use at most clinics and all down referral sites (Table
3). HIV treatment data were manually recorded on six
different forms including an ARV monitoring register to
record individual patient data at monthly follow-up vis-
its, and five other forms, two of which respondents
referred to as “DORA reporting tools” (Table 4). As
shown in Table 4, the ARV monitoring register was in
use at both down-referral sites (completed by nurses)
and both CCMT sites (completed by data clerks). Infor-
mants at both down-referral sites and one CCMT site
reported that staff did not use the other five ART data
recording forms because they found them to be too
complicated to complete.
In total 201 HIV data elements were recorded, though
some were duplicated-e.g. the same VCT data was
Table 1 Study sample and participants
Type of facility Type of HIV service No. in sample Data collection tools
Hospital* HIV treatment (ART site) 2 Facility checklist
Community health centre
@ HIV prevention** HIV treatment (DR site)
# 2 Facility checklist
Primary care clinic HIV prevention 7 Facility checklist
Interview participant Level of health system No. in sample Data collection tools
Facility (operational) manager Health facility 11 Semi-structured questionnaire
HIV programme manager Provincial 4 In-depth interview guide
*These are dedicated HIV treatment clinics located within the hospital
**HIV prevention services include VCT, PMTCT, TB/HIV collaboration services, and PEP
@Like clinics, community health centres (CHC) are nurse-driven health facilities providing primary care services. Clinics offer an 8-hour daily service; CHCs offer a
24 hour services, including maternity delivery services.
#DR = down-referral ART site
Table 2 Variables measured in the study
Variables Definition
Design of the HIV M&E* ▪ Existence of an M&E framework and plan
▪ Definition of data elements/HIV indicators
▪ Availability of financial resources
▪ Existence and staffing of M&E unit
Activities for the production of HIV
information
▪ Collection: number of data recording forms in use; number and purpose of HIV data elements recorded.
▪ Collation and reporting: number of data collation forms; mechanisms to transmit data from facility to higher
levels of health system, format for reporting and audience.
▪ Analysis: approach to HIV data analysis at different levels of the health system.
Availability of HIV information ▪ Whether HIV indicators are disseminated to and available at the district level.
Extent of HIV M&E and DHIS
integration
Extent of sharing of:
▪ Collection: personnel and forms that record HIV and DHIS data.
▪ Collation and reporting: personnel and forms that collate HIV and DHIS data; reporting pathways and
mechanisms, and audience to whom HIV and DHIS indicators are sent.
▪ Analysis: shared personnel and analytic approach for HIV and DHIS data.
*This variable measures whether the required organizational attributes of an M&E system are in place [4,34].
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data forms for June 2009 revealed that while VCT regis-
ters at all clinics and down-referral sites and the ARV
patient monitoring register at one CCMT site were
complete, all other forms had missing fields or were not
used at all. Facility managers attributed the incomplete
recording and non-use of forms to their staff not being
trained, particularly on newly-introduced data elements
and registers.
Staff at clinics and down-referral sites designed and
used their own additional HIV forms (Table 6). For
example, some designed registers to track patients who
were eligible for ART, which the nationally-defined
forms did not appear to enable them to do. Neither
CCMT site implemented additional facility-specific
forms, but respondents reportedly observed this practice
at other CCMT sites in the province:
“Initially when the program started, they sort of used
note books before we could introduce this tool. So it
is difficult for them to change from their note books
to the tools; they think the [DORA] tools are a bit too
complicated. They stick to their note books. But you
will find one facility having more than five or eight
Table 3 Use of nationally-designed forms for recording HIV prevention data
Type of form Description of form Use of form at primary care
clinics (n = 7)
Use of form at DR sites (n = 2)
All forms were tick registers No. of
clinics
using form
Health worker
completing the
form
#
No. of DR
sites using
form
Health worker
completing the
form
#
PHC (HIV)
register*
Records data on VCT, PMTCT, CD4 test before ART,
management of TB/HIV co-infected patients, referrals to ART
service.
6 Lay counsellor 2 HIV nurse
VCT register** Records data on HIV counselling, HIV testing, and HIV result
for different client types (pregnant women, TB patients,
others).
7 Lay counsellor 2 Lay counsellor
Antenatal NVP
register
Records data on Nevirapine (NVP) dispensed to HIV positive
pregnant women for PMTCT.
6 PHC nurse 2 Maternity nurse
Antenatal
PMTCT
register***
Records data on Zidovudine (AZT) dispensed to HIV positive
pregnant women for PMTCT.
5 PHC nurse 2 PHC nurse
#In both clinics and DR sites, PHC nurses (provide general care) also complete the DHIS register. ‘HIV nurses’ did not use the DHIS form.
*The PHC (HIV) register was introduced in early 2009, and a revised version was introduced in June 2009.
** The VCT data that this form collects are also recorded on the PHC (HIV) register.
*** This form was introduced in May 2009 (2 months before data collection) after inception of dual therapy for PMTCT.
Table 4 Use of nationally-designed forms for recording HIV treatment (ART) data
Name of form or
register
Brief description of form No. of ART (CCMT)
sites using this form
(n = 2)
No. of ART (DR) sites
using this form (n =
2)
For recording HIV treatment (ART) data-for M&E reporting
ARV patient treatment
monitoring register
This records individual patient data-ART regimen, CD4 and viral load
levels, and patient weight. Data from this register are tallied on the
ARV patient M&E and DORA tally sheet (described below).
22
ARV patient M&E data
elements collection tally
sheet
This sheet tallies-by age, sex, and pregnancy status-No. eligible for
ART, type of ART regimen. It records No. of activities and not
individuals.
00
ARV laboratory data
collection tally sheet
This sheet tallies number of CD4 count and viral load tests done-those
at staging visits (baseline) and at 6-month follow-up visits. Data are
not patient-linked.
10
ARV patient nutritional
supplements tool
This form records the number of various nutritional supplements
disbursed to HIV + patients, weight, and No. of deaths.
00
For recording HIV treatment (ART) data-DORA reporting
ARV patient DORA data
elements collection tally
sheet
This form tallies the No. Of patients assessed for ART, commenced on
ART, deregistered, and adherent to ART. It also records clinical and
biological monitoring of ART patients. Data are activities and not
patients.
00
Daily stock-out control
tool
This form records the number of days nutritional supplements and
specified drugs are out of stock in any given month.
10
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books, because initially they have been made to
improvise to use note books, so is not easy for them
to change”.(programme manager)
HIV prevention data that were recorded on VCT and
PMTCT registers were manually aggregated by senior
nurses on a DHIS monthly collation form and submitted
to the sub-district level where the information officer
captured the data on DHIS software and transmitted it
electronically to the district and then the provincial
health information unit. Analysis at sub-district and dis-
trict level generated DHIS and HIV prevention indica-
tors. ART data were collated on a monthly ARV
collation form by data clerks at both CCMT sites (the
two DR sites sent their data to CCMTs site for col-
lation) and submitted directly to the HIV M&E unit
where the HIV M&E manager captured and aggregated
the data as counts and no analyses were done (Figure 1).
Availability of HIV indicators at district level
From the provincial level, HIV data were submitted to
the National Health Department (prevention and ART
data) and the National Treasury Department (ART data)
(Figure 1). The latter was referred to as “DORA report-
ing”. The HIV M&E manager compiled the DORA
report which included ART data and a few VCT and
PMTCT indicators (supplied by the provincial informa-
tion unit). HIV prevention data were available at the dis-
trict level (as they were incorporated into the DHIS) and
included in the district quarterly review (DQR)-a pro-
cess where district health managers use health service
data to review district performance. CCMT data were
shared amongst HIV programme managers at provincial
Table 5 Number of HIV data elements collected with nationally-defined forms
Aspect of HIV service and type of form used to record data No. of data elements recorded
HIV prevention data: recorded on the PHC (HIV) register 44
VCT 9
PMTCT 12
TB/HIV collaboration services 7
Post-exposure prophylaxis for rape survivors 8
Assessment for ART 7
STI treatment in ART patients 1
HIV prevention data: recorded on the VCT register 11
VCT service use 11
HIV prevention data-recorded on PMTCT registers 11
Nevirapine dispensed to pregnant women 4
AZT dispensed to pregnant women 7
HIV treatment data-recorded on ART register and tally sheets 135
ART assessment-for ART eligibility and drug readiness 25
ART follow-up-clinical, laboratory, drug regimen (register) 9
Viral load and CD4 testing-at baseline and follow-up (tally) 36
Dispensing of nutritional supplements (tally) 22
ART services-tally of activities for ART assessment and follow-up 33
Stock control-tally of stock outs in previous month 10
Table 6 Facility-specific forms for recording HIV data
Types of data collected with facility-specific forms* No. of clinics (n = 7) No. of down-referral sites (n = 2)
VCT service use 5 1
CD4 testing and results by patient name 4 2
TB/HIV prevention (collaboration) - 1
Pre-ART support, ART readiness, referral to CCMT site for ART 6 2
Down-referrals from ART site N/A 2
No. of facility-specific forms in use per facility
No. of facilities using 1 facility-specific form 1 -
No. of facilities using 2-3 forms 6 -
No. of facilities using > 3 forms 0 2
*None of the CCMT sites developed facility-specific data recording forms
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Page 6 of 13National Level: 
Department of Health  
(Health Information 
Unit) 
  National Level:  
Department of 
Health  
(HIV Programme) 
  National Level:  
Treasury 
Department 
Provincial Level:  
Department of Health  
(Health Information 
Unit) 
  Provincial Level:  
Department of 
Health  
(HIV Programme) 
  Provincial Level:  
Treasury 
Department 
District Level:  
Department of Health  
 
Sub-district Level: 
Department of Health 
 
Facility Level:  
Primary care 
clinics 
  Facility Level:  
ART (down 
referral) sites 
  Facility Level:  
ART (CCMT) 
sites 
  Flow of DHIS data – via existing channels of DHIS reporting 
  Flow of HIV prevention data – via existing channels of DHIS reporting 
  Flow of HIV treatment (ART) data – via separate fast-track data reporting channels 
  Copy of collated ART data to district level – theoretically, and not done in practice 
Figure 1 flow of HIV and DHIS data through various levels of the health system. The flow of HIV data and DHIS data from the health
facility level (where data are recorded) to the national level of the health system was described, based on the data obtained through key
informant interviews and review of M&E documents at facility level. The figure indicates that the flow of HIV treatment data is separate from and
parallel with the flow of DHIS data.
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and not included in the DQR process.
Integration of the HIV M&E with the health system M&E
function
Overall, the prevention sub-programme was partially
integrated with the DHIS-data collection activities were
partially integrated while the rest were fully integrated-
while the treatment (ART) sub-programme M&E was
not integrated with the DHIS (Table 7).
Respondents reported that ART data were coordinated
separately to ensure DORA reporting deadlines were
met, and because there was little confidence in the
DHIS, as illustrated below:
“Because the CCMT data has got this political pres-
sure of saying that by the 10th we are supposed to
report at the National Department of Health. That is
w h yb yt h e3 r dt h e ya r es u p p o s e dt ob ef a x i n g
directly. If we say they should report at the sub-dis-
trict level then data is going to take a month to be at
the provincial office, of which it is unacceptable.”
(programme manager)
“And another thing with the data that we are getting
from the CCMT sites, ideally one would be even
more happy if we were getting that data through the
normal health facility data reporting, through the
district health system. But it is not falling in the dis-
trict health system; it goes directly from the facility to
the province. And the only reason for that ...it’s
because, it says we are not confident with the data
flow system and if we were to follow that data flow
system as we should, probably we would be having
nothing.” (programme manager)
Discussion
The HIV M&E system described in this study essentially
meets the organisational requirements of a national
M&E system, but has several limitations that affect its
efficiency and utility and constrain the availability of
HIV data. Below we discuss these limitations and factors
that may influence HIV M&E integration in South
Africa. Finally, we use our case study findings to pro-
pose some ideas about how integration can strengthen
health systems and maximise programme-system
synergies.
Limitations of the HIV M&E system
The M&E system is designed and implemented in a top-
down uncoordinated manner. It is characterised by a
massive data set, duplication of data collection, incom-
plete data recording, and non-use of nationally-defined
forms. These features have been shown to limit the effi-
ciency and accuracy of HIV M&E systems in other set-
tings [4,37]. Our findings indicate these problems exist
because the HIV M&E was seemingly designed in an
uncoordinated and top-down and manner-some data
were collected but not collated and analysed, data forms
were introduced without ensuring they did not duplicate
Table 7 Extent of integration of the HIV M&E system with the DHIS
M&E activity HIV prevention sub-programme HIV treatment sub-programme
Overall: partial integration Overall: no integration
Data collection partial integration no integration
Data recording forms Forms for HIV prevention data are separate from DHIS forms. Forms for ART data are separate from DHIS forms.
Personnel who
record the data
Dedicated HIV personnel record most prevention data; some sharing
only at clinics where PHC nurses record some PMTCT and all DHIS
data.
Dedicated CCMT data clerks capture only ART data.
Data collation and
reporting
full integration no integration
Data collation forms Data are collated on the standard monthly collation form that is
used for DHIS data.
DORA monthly collation form-separate from DHIS data
collation form.
Data reporting (also
see Figure 1)
Data reported through DHIS reporting mechanisms. Data reported through dedicated channels separate
from the DHIS.
Data analysis full integration no integration
Approach and level
at which data
analysed
Same analysis approach as DHIS; analysis at sub-district and district
levels by same staff who analyse DHIS data.
DORA reports analysed at national level-separate
analysis from DHIS.
Dissemination full integration no integration
Information
dissemination
processes
Indicators disseminated through the DHIS to managers at district
and provincial levels.
DORA reports disseminated to the National Treasury
and National Departments of Health-not through the
DHIS.
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health workers’ p e r c e p t i o n so ft h ef o r m sw e r en o t
considered.
Another feature of the uncoordinated design is that
the M&E system (particularly the ART component) lar-
gely generates data on service quantity (e.g. the number
of people on ART) rather than service quality and out-
comes. This skewed focus could be because service
quantity data are needed for conditional grant reporting,
but is limited as a good M&E system should also gener-
ate patient outcome indicators to monitor programme
performance [1] and service quantity data are not suffi-
cient to monitor performance. The limited utility of the
HIV M&E is underscored by a recent report that despite
the large amount of data gathering activity, the HIV
programme has insufficient information to guide action
[38]; and research which shows that routinely collected
public sector ART service data do not allow monitoring
of key performance measures like death, loss to follow-
up and retention in care [39].
A further limitation of the HIV M&E system is that its
vertical design contradicts the notion of integrated man-
agement. While M&E activities for the production of
HIV prevention data are integrated with the DHIS,
those for the production of HIV treatment data are not,
which creates silos within a silo-i.e. within the vertical
HIV programme, parallel M&E processes for prevention
and treatment data. This silo approach is not unique to
South Africa. In other settings distinct M&E systems for
different components of the HIV programme exist, with
health facilities reporting separately on each component
[3]. In our study, the silo M&E approach could poten-
tially promote divisions in the management of HIV sub-
programmes, which contradicts stated goals of an inte-
grated HIV/AIDS response [23]. The silo approach also
limits the availability-and potential use-of ART informa-
tion at district level because ART data by-pass the
DHIS, and undermines national policy intents of inte-
grated district management [29,30].
Factors influencing integration of the HIV M&E system
A recent systematic review of the evidence on integra-
tion of disease-specific programmes into health systems
reveals a dearth of analyses of the information (M&E)
building block. That review also reveals a “highly hetero-
geneous picture” with programmes integrating with dif-
ferent health system functions to varying extents-though
the dearth of cross-site comparable data precludes firm
conclusions about which factors impede and promote
integration [13]. The evidence however suggests that
context-specific factors related to health system charac-
teristics (e.g. fragility, absorptive capacity) and the poli-
tico-economic and socio-cultural context (e.g.
commitment of national leadership, health personnel
preferences) influence the extent of integration [13].
Based on our study, we propose that the following poli-
tico-economic and health system factors may influence
integration of the HIV M&E system.
Politically-driven ART exceptionalism in a post-AIDS
denialism era
Initially conceptualized as an integrated programme in
line with national policies, the HIV programme was
however introduction as a targeted intervention with
special access to ear-marked funding [40,41]. This AIDS
exceptionalism-treating AIDS as different from other
public health threats [42], was fuelled by fears of health
system incapacity and pressure to quickly curb a grow-
ing HIV epidemic [40,41]. At its inception the HIV pro-
gramme however focussed only prevention activities,
and HIV treatment was introduced much later, follow-
ing pressure and legal action from civil society actors
[43]. Government’s delayed action on ART provision,
largely attributed to the then-president Mbeki’sA I D S
denialism [43], resulted in a huge unmet need for ART
in South Africa [44].
The introduction of public sector ART provision in
2004, hailed as an essential step forward, was however
accompanied by a significant shift in focus from HIV
prevention to treatment. This ART exceptionalism
(prioritising ART above other HIV control foci)-as evi-
denced by the preferential funding and resources for
ART M&E observed in this study-was seemingly a bid
to meet new ambitious ART coverage targets to address
the huge backlog. ART prioritisation has been heigh-
tened further following the launch in April 2010 of a
presidential HIV counselling and testing (HCT) cam-
paign to test 15 million sexually-active adults for HIV
by June 2011, and new guidelines for earlier ART initia-
tion of pregnant women, TB patients and children
[45,46]. These initiatives have accelerated country-wide
accreditation of many primary care facilities (clinics and
community health centres) as CCMT sites [47]. In our
study province, accrediting all primary care facilities
would lead to a 10-fold increase in the number of
CCMT sites, which raises questions about the long-term
sustainability of a non-integrated ART M&E.
Ear-marked HIV funding
The desire for control over their funded programme
often drives donors to continue supporting even inap-
propriate vertical systems [21]. Research shows GHI-
supported systems often satisfy donor interests, and
undermine recipient priorities, often contradicting
donors’ stated aims to harmonise in-country coordina-
tion [12,48,49]. Like many donors, National Treasury
reporting requirements-reflecting a desire to closely
monitor the conditional grant-facilitate an M&E system
that does not primarily serve the interests of recipient
provinces and is at odds with the notion of integrated
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mechanism for government to ensure provinces spend
on national priorities [50], its reporting mechanisms are
at odds with the DORA legislation through which it is
administered. The DORA states that systems for moni-
toring the conditional grant should not impose an
“undue administrative burden” on recipients and “should
be compatible and integrated with” other systems [51].
Lack of confidence in the capacity of the national health
information system
Respondents in our study expressed concerns about the
capacity of the DHIS to manage and ensure timely
reporting of data. DHIS weaknesses reported in the lit-
erature include poor quality data, incomplete reporting,
delayed availability of information, low data use, and
inadequate information management skills of DHIS per-
sonnel [31,52,53]. The existence of weaknesses should
however not justify a silo M&E approach whereby ART
data by-passes the DHIS to fast-track reporting to the
national level. Using DHIS weakness to justify non-inte-
gration of M&E systems sends an incorrect message
that the primary purpose of M&E is to submit data
‘upwards’ to higher levels for their use when in fact the
message should be that M&E systems must principally
support sub-national levels (districts) as the primary
users of information. It is also a missed opportunity to
strengthen the capacity of the DHIS to oversee the pro-
duction of HIV information and ensure its use within
the overall health system M&E function.
Proposals for integration to maximise positive
programme-system synergies
Maximising positive synergies between programmes and
health systems is about finding practical ways in which
disease-specific and health system functions can posi-
tively interact for optimal health benefit [54]. Below we
highlight some ideas of what this may mean at sub-
national (district) level, using our South African case
study as an example.
The vertical HIV M&E system observed in this case
study promotes fragmented health system coordination
and seemingly benefits neither the HIV programme nor
the health system. For HIV M&E systems set up like
this we propose integration with the overall health infor-
mation system (HIS), while strengthening HIS capacity
to absorb new roles. Integration should be coupled with
re-design of the HIV M&E system to ensure only a
small set of relevant HIV data are collected to address
needs at different levels of the health system, and to
rationalise data reporting such that health facilities
report up the health system hierarchy less frequently
and only on a select set of priorities. Most data could
rather be incorporated into supervision systems so facil-
ity managers and district managers use them for
continuous monitoring and service improvement [55].
Inculcating data use to support health management at
these levels contributes to South Africa’s re-engineering
primary health care (PHC) strategy [56].
A few other issues would need to be considered. First,
HIV M&E integration entails alignment of both opera-
tional and administrative (or managerial) integration
[21]. Operational integration would mean integrating
HIV data collection and collation forms, data analysis
software and templates, and information dissemination
mechanisms with those of the overall HIS; and absorb-
ing all HIV M&E-specific personnel (clerks, information
officers and managers) within the HIS. It has been
shown that the success of any changes to operational
processes requires also paying attention to management
issues [57]. As such managerial integration would mean
assigning responsibility for overseeing the production
and use of disease-specific information to district man-
agers (rather than programme managers) and building
their M&E skills. Enabling managers at the district level
in this manner is a way of promoting integrated health
management, especially in decentralised health system
settings [58,59].
Second, HIV M&E integration should occur alongside
overall HIS strengthening. This undoubtedly requires
resources, but some costs may be offset by efficiency
gains due to reduced duplication consequent on integra-
tion [60]. For HIV M&E integration to maximise pro-
gramme-system synergies, ear-marked HIV resources
could be leveraged and channelled to develop overall
H I Sc a p a c i t yt op r o d u c em o r et i m e l ya n dr e l i a b l ed i s -
ease-specific and general service data. For example, HIV
funding could be used to pay salaries of absorbed HIV
M&E personnel, train staff, and improve HIS infrastruc-
ture. Lessons can be drawn from integration of HIV
laboratory services in Nigeria, whereby using ear-marked
HIV funding to train all laboratory personnel and reha-
bilitate general laboratory infrastructure improved the
quality of laboratory performance and benefitted both
HIV programme and health system goals [61].
Third, the process of integration should be considered.
We propose a phased process guided by operational
research, and a bottom-up approach including relevant
role players to engender ownership and enhance accep-
tance of new ways of working [59]. This means recog-
nizing actors at lower levels of the health system and
enabling them to take a lead role in their respective jur-
isdictions without always having to await approval from
‘the top’. The fact that health care providers at clinic
level in our study developed their own systems suggests
that there is problem-solving capacity at sub-district
level and this should be tapped, encouraged and sup-
ported. It also means getting consensus on actions and
timelines, building trust amongst actors, and
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ble re-distribution of roles because, as experience shows,
those who lose responsibilities may try to re-assert their
positions by undermining the process [59].
It is well documented in the literature that it is often
donor demands that drive vertical reporting of data in
low and middle income countries, often placing a heavy
data reporting burden on health services. Our study pro-
vides a less-documented situation in which national gov-
ernment (funder) demands on sub-national levels
(recipients) drive duplicate reporting and undermine
data availability and use at district level. Though we
used one case study district we expect the findings
documented here to be transferable to other district
municipalities in South Africa, especially in provinces
that operate HIV M&E systems in parallel to the DHIS.
We acknowledge that comprehensive HIV programme
integration cannot address the M&E function in isola-
tion. Research is thus needed to understand HIV pro-
gramme interactions with other health system functions.
For a complete picture of programme integration in
South Africa, further research should examine how
other targeted programmes interact with the health sys-
tem. Work is also needed to understand interactions
and possible tensions between programme and health
system managers-an important aspect of integration not
addressed in this study [21,62]. We anticipate that the
issues highlighted here can inform further studies.
Finally, though availability of information at the district
level is a necessary first step, we recognise that the pur-
pose of M&E is information use [7] and so recommend
further research to understand if and how programme
information is used at district level.
Conclusions
We have highlighted some of the limitations of vertical
HIV M&E systems, and some broad factors that my
influence their non-integration with the health system.
Using a South African case study, we propose integra-
tion of the HIV M&E system with the overall health
information system (HIS), while concurrently addressing
any HIS weaknesses and building programme M&E
skills of health system personnel. We view M&E integra-
tion as being about more than just merging data record-
ing forms and reporting and dissemination mechanisms.
It is about breaking away from historical silo funding
that promotes disease-specific M&E systems over
strengthening overall health information systems and
about building the capacity of HIS personnel and health
system managers to take on programme-specific M&E
coordination responsibilities. It is an incremental learn-
ing process that will require political commitment and
investment of time and resources. Leveraging ear-
marked HIV funding to provide the needed resources to
build overall HIS capacity is a practical way of translat-
ing health system strengthening intents of national HIV
policy into tangible action.
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